Michael Shetzline - 17 Jan 2025 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
SVP, CMO, Head-Res&Drug
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
17 Jan 2025
Transactions value $
$0
Form type
4
Filing time
22 Jan 2025, 17:04:41 UTC
Previous filing
22 May 2024
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +48.2K +11.66% $0.00 462K 17 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 2, 2022. The earned PSUs were certified and vested on January 17, 2025.